Portfolio company
Neuro Modulation Artificial Retina
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pixium Vision
This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
LambdaVision
This company develops protein-based artificial retinas in microgravity to restore vision for patients with retinitis pigmentosa and age-related macular degeneration.
Neurotech
This biotechnology company develops encapsulated cell therapy implants to treat chronic retinal diseases for patients with macular telangiectasia and other eye conditions.
RhyGaze
This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Ray Therapeutics
The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
